At what intervals should a pediatric patient receive Tdap (tetanus, diphtheria, and acellular pertussis) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tdap Vaccination Schedule for Pediatric Patients

Pediatric patients need Tdap only once, administered as a single dose at age 11-12 years. This is not a recurring vaccine in childhood—it's a one-time booster dose during adolescence.

Standard Vaccination Schedule

The routine recommendation is straightforward 1:

  • Single dose of Tdap at age 11-12 years (preferably at age 11-12 years)
  • This dose is given after completion of the childhood DTaP series (typically 5 doses by age 4-6 years)
  • No routine repeat doses of Tdap are recommended in the pediatric/adolescent age group

Important Age-Specific Considerations

Children Under Age 10

  • Tdap is NOT licensed or indicated for children younger than 10 years 2
  • Children ages 2 months through 6 years should receive DTaP (the pediatric formulation), not Tdap
  • If Tdap is inadvertently given to a child under age 10, it generally should not count as valid, and the adolescent Tdap dose should still be given at age 11-12 years 1

Age 10 Years

  • If Tdap is administered at age 10 years, this dose counts as the adolescent Tdap dose and does not need to be repeated 3, 4
  • However, if given at ages 7-9 years, the child should still receive the routine adolescent Tdap at age 11-12 years 3, 4

Minimum Interval Considerations

While Tdap is typically given only once in adolescence, when catch-up vaccination is needed:

  • At least 5 years between the last Td dose and Tdap is encouraged in routine situations 2, 5, 2
  • However, shorter intervals (even as short as 18 months) can be used safely when necessary, though with slightly increased local injection site reactions 6, 7

Special Circumstances Requiring Catch-Up

Incomplete Childhood Vaccination

For adolescents aged 11-18 years who never received a complete DTaP series 2:

  • Give a series of three tetanus-diphtheria toxoid-containing vaccines
  • Preferred schedule: Single Tdap dose, followed by Td >4 weeks later, then another Td dose 6-12 months after that
  • Tdap can substitute for any one of the three Td doses in this series

Children Ages 7-10 Years with Incomplete Vaccination

  • These children should receive Td (not Tdap) for catch-up 2
  • When they reach age 11-12 years, they should then receive their single adolescent Tdap dose

Critical Pitfalls to Avoid

  1. Don't confuse DTaP with Tdap: DTaP is for children <7 years; Tdap is for ages ≥10 years (Boostrix) or ≥11 years (Adacel) 1, 5

  2. Don't give multiple Tdap doses routinely: Tdap is licensed as a single-dose booster, not for multiple administrations in the general pediatric population 1 (exception: pregnant women receive Tdap with each pregnancy, but this applies to adults)

  3. Don't delay the adolescent dose unnecessarily: While a 5-year interval from the last tetanus-containing vaccine is encouraged, protection from the childhood DTaP series wanes significantly, making timely Tdap administration at age 11-12 years important 8

  4. Age 10 is the key threshold: A Tdap dose given at exactly age 10 years counts as the adolescent dose and doesn't need repeating, but doses at ages 7-9 years do not count 3, 4

After the Adolescent Dose

Following the single Tdap dose at age 11-12 years:

  • No additional pertussis-containing vaccines are routinely recommended during adolescence
  • The next tetanus-diphtheria booster (Td, not Tdap) would typically be recommended 10 years later in adulthood 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.